Official updates, analyst briefs, and approved resources for TCS and bioStealthAI.
EDITORIAL RESOURCES
Usage note: Approved assets for editorial use. For exceptions, request approval. Do not alter marks, proportions, or colors. Avoid complex backgrounds.
Featured
Featured Image
LONDON, UK, September 28, 2026 - BiostealthAI® has secured a Hong Kong patent grant covering its Touchable Cardiovascular Surfaces technology, extending the international reach of the company’s foundational intellectual property for physiological sensing through everyday touch surfaces.
All news
News Image
LONDON, UK, September 28, 2026 - BiostealthAI® has secured a Hong Kong patent grant covering its Touchable Cardiovascular Surfaces technology, extending the international reach of the company’s foundational intellectual property for physiological sensing through everyday touch surfaces.
News Image
LONDON, UK— May 6, 2026 — BiostealthAI® has secured a European patent grant for Touchable Cardiovascular Surfaces, strengthening the company’s intellectual property position around surface-level physiological sensing.
News Image
LONDON, UK— March 26, 2024 — BiostealthAI® today announced it has joined NVIDIA Inception, a programme that nurtures startups revolutionising industries with technological advancements.
News Image
LONDON, UK— February 8, 2024 — BiostealthAI®, is thrilled to announce its participation in the London Health Accelerator Programme for Social Enterprise operating in London’s health and life sciences sector. Developed in collaboration between MedCity and the School for Social Entrepreneurs, this programme aims to equip participants with essential skills, mentorship, knowledge, and connections to grow and scale their social enterprises while addressing health disparities in underserved communities.
News Image
BiostealthAI is proud to announce we've successfully been selected for the Product Growth Programme powered by Barclays Eagle Labs, funded by the UK Government and delivered by Plexal.
News Image
LONDON, UK— December 1, 2023 — BiostealthAI has released the preliminary findings of its ongoing usability study evaluating the effectiveness of its flagship Touchable® device and health management platform. The study is designed to assess the functionality of the hardware and overall usability of the health management platform among elderly individuals suffering from chronic respiratory conditions such as COPD.
News Image
BiostealthAI is thrilled to announce its selection for the Simulation for Digital Health (SimDH) programme. Co-funded by the European Regional Development Fund, SimDH offers invaluable support to health tech start-ups and SMEs, empowering them to innovate, develop, and deliver groundbreaking products and services.
Selected insights from TCS architectural whitepapers.
Access in-depth technical insights and research findings.